The abstract is read at the publisher; the summary is JClub's.
A single heterozygous carrier of MUTYH p.Gly396Asp shows SBS18 across multiple normal tissues, ranking first among 25 SMaHT donors.
- Why it matters: It is unclear whether common monoallelic MUTYH carriers develop an oxidative mutational phenotype in healthy tissue, despite SBS18 being linked to biallelic MUTYH loss.
- What they did: Multi-tissue sequencing from 25 SMaHT donors identified three heterozygous carriers; one was assessed with three independent methods for SBS18 and checked for second-hit evidence at the MUTYH locus.
- The result: SBS18 persisted after adjustment for tissue and showed no somatic, epigenetic, or transcriptional second hit, implying tissue-level mutational readouts may support cancer risk stratification in this carrier state.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.